Edwards Lifesciences
- EW
- NYSE
- Consumer Products
- Latest 66.37
- Currency US$
- Change -0.69
- Percent Change -1.029 %
- Volume 2,338,426
- Mon May 20, 2013 4:01 PM EDT NYSE data delayed 15 minutes.
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
Price Ratios
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | Apr 23 | $0.76 | Jul 23 | $0.77 |
| Surprises | Apr 23 | -5.26% | n/a | n/a |
| Dividends | n/a | n/a | n/a | n/a |
| Splits | n/a | -- | n/a | n/a |
12 months ended May 21, 2013.
A look at major corporate events and financial announcements that are coming up.
About the Company
Edwards Lifesciences Corp. a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, peripheral vascular disease and critical care technologies. The company's global brands, which are sold in approximately hundred countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, LifeStent, PERIMOUNT Magna and Swan-Ganz. Edwards Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards Lifesciences Corporation and are registered in the United States Patent and Trademark Office. LifeStent is a trademark of Edwards Lifesciences AG and is registered in the United States Patent and Trademark Office.
Officers
Head Office
ONE EDWARDS WAY
Phone: 9492502500
Fax: (949)-2502525